• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

Advertisement

Organisation › Details

Biocrates Life Sciences AG

BIOCRATES Life Sciences AG, founded in Innsbruck in 2002, is a leading biotechnology company focused on metabolomic biomarker discovery and development of in vitro diagnostics for early disease detection and progression in areas such as endocrinology, diabetes, nephrology, and oncology. Biocrates believes that, in the near future, mass spectrometry (MS) - due to its high quality performance - will play an increasingly important role in laboratory medicine. Biocrates considers itself to be in a unique position of becoming the leading provider of MS-based standardized IVDs with unprecedented accuracy, precision and multiplexing potential which will help to revolutionize the way personalized medicine is applied in practice. *

 

	Start	2002-01-01 established
	Predecessor	Biocrates Life Sciences GmbH
	Industry	LIFE SCIENCES
	Industry 2	metabolomics
	Region	Innsbruck
	Country	Austria
	Street	66/2 Innrain
	City	6020 Innsbruck
	Tel	+43-512-579823
	Fax	+43-512-579823-4270
		Address record changed: 2009-09-28
Basic data	Employees	n. a.
		* Document for »About Section«: Biocrates Life Sciences AG. (5/16/11). "Press Release: Setting New Standards in Steroid Hormone Analysis. SteroIDQ Kit by Biocrates Life Sciences AG". Innsbruck.
		Record changed: 2011-11-25

More documents for Biocrates Life Sciences AG

• [1] Biocrates Life Sciences AG. (6/27/11). "Press Release: Biomarker Research May Revolutionize Early Detection of Colorectal Cancer". Vienna....
• [2] Biocrates Life Sciences AG. (5/16/11). "Press Release: Setting New Standards in Steroid Hormone Analysis. SteroIDQ Kit by Biocrates Life Sciences AG". Innsbruck....
• [3] Biocrates Life Sciences AG. (2/16/11). "Pressemitteilung: OMICS – auf dem spannenden Pfad der personalisierten Medizin". München....
• [4] Biocrates Life Sciences AG. (1/13/11). "Press Release: Metabolomic Biomarker Research for the Early Detection of Diabetes. International Expert Meeting on the Current Status, Benefits, and Opportunities of Metabolomics in the Nutritional Sciences, Diabet...
• [5] Biocrates Life Sciences AG. (12/7/10). "Press Release: Biocrates Expands Management Board. New Chief Technology Officer (CTO) Dr. Ralph Zahn". Innsbruck....
• [6] Biocrates Life Sciences AG. (11/15/10). "Press Release: Austrian Biocrates Life Sciences AG Announces Launch of Its First Metabolomics-based Clinical Research Kit – MetaDisIDQ Kit"....
• [7] Biocrates Life Sciences AG. (9/6/10). "Press Release: Austrian Biocrates Life Sciences AG Announces Launch of Its Second Mass Spectrometry-based Metabolomics Research Kit – AbsoluteIDQ p180 Kit". Innsbruck....
• [8] Biocrates Life Sciences AG. (8/25/10). "Pressemitteilung: Biocrates erhält erp-Technologiekredit. Tiroler Biotechnologieunternehmen wird von der aws gefördert". Innsbruck....
• [9] Biocrates Life Sciences AG. (8/19/10). "Press Release: Austrian Biocrates Life Sciences AG and Swiss Selexis SA Join Forces to further Optimize High-yield Mammalian Cell Cultures for the Production of Protein Pharmaceuticals"....
• [10] Biocrates Life Sciences AG. (3/31/10). "Press Release: Biocrates Life Sciences AG Joins SysKid, a European Research Consortium Refining the Diagnosis and Treatment of Chronic Kidney Disease". Innsbruck....

To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com

» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2012. Made in Germany.